Caixin App
Newsletter
Weekly Magazine
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Commentary & Analysis
Weekend Long Read
Video
ESG
Topics
China Goes Global
Asia New Vision Forum 2025
Asia New Vision Forum 2024
Selected
CX Daily
Weekly Must-Read
Caixin Briefs
Economic Indexes
Caixin Explains
News Graphics
ThinkChina
Podcast
Highlights
Newsletter
Events
Impact
Asia Central Banking
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
chen xi
$100 Million AstraZeneca Deal Puts Chinese Biotech Jacobio on Path to Profit
Hutchmed Pulls Cancer Drug in China After U.S. Partner Flags Safety Risks
In Depth: China’s Biotech Push Into Small Nucleic Acid Drugs Draws Global Pharma
Innovent Deepens Eli Lilly Tie-Up With Potential $8.9 Billion Drug Deal
China’s Vaccine Exports Rebound as Drugmakers Look Abroad
In Depth: China’s Tech Giants Burn Cash to Try to Dominate AI Health Care
AbbVie Bets Big on Chinese Cancer Drug in $5.6 Billion Licensing Deal
Chinese Drugmakers Strike Record $136 Billion in Cross-Border Licensing Deals
AI Drugmaker Insilico Strikes $888 Million Cancer Drug Deal With Servier
Jacobio Pharma Signs $2 Billion Deal With AstraZeneca for Cancer Drug
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通